By leveraging computational biology, this company is developing innovative drug designs to combat cancer, neurodegenerative diseases like Alzheimer's, and the aging process itself. Their approach involves analyzing vast amounts of biological data to identify new drug targets and optimize drug efficacy. By combining cutting-edge technology with deep expertise in molecular biology and drug development, they aim to bring new treatments to market that can improve the lives of patients suffering from these devastating diseases.